share_log

Intelligent Bio Solutions | CORRESP: CORRESP

Intelligent Bio Solutions | CORRESP: CORRESP

Intelligent Bio Solutions | CORRESP:信函
SEC announcement ·  03/13 13:08
Moomoo AI 已提取核心信息
Intelligent Bio Solutions Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, headquartered in New York and incorporated in Delaware, submitted the request via a letter dated March 13, 2024, addressed to the SEC's Division of Corporate Finance. Intelligent Bio Solutions Inc. seeks to have the Registration Statement become effective at 4:30 P.M. Eastern Time on March 15, 2024. The request was signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3. The company, headquartered in New York and incorporated in Delaware, submitted the request via a letter dated March 13, 2024, addressed to the SEC's Division of Corporate Finance. Intelligent Bio Solutions Inc. seeks to have the Registration Statement become effective at 4:30 P.M. Eastern Time on March 15, 2024. The request was signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc.已正式要求美国证券交易委员会(SEC)加快其S-3表格注册声明的生效日期。该公司总部位于纽约,在特拉华州注册成立,通过2024年3月13日致美国证券交易委员会企业融资部的信函提交了申请。Intelligent Bio Solutions Inc.希望注册声明于美国东部时间2024年3月15日下午4点30分生效。该请求由智能生物解决方案公司首席财务官斯皮罗·萨基里斯签署。
Intelligent Bio Solutions Inc.已正式要求美国证券交易委员会(SEC)加快其S-3表格注册声明的生效日期。该公司总部位于纽约,在特拉华州注册成立,通过2024年3月13日致美国证券交易委员会企业融资部的信函提交了申请。Intelligent Bio Solutions Inc.希望注册声明于美国东部时间2024年3月15日下午4点30分生效。该请求由智能生物解决方案公司首席财务官斯皮罗·萨基里斯签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息